EUVIMEDEUVIMED entdecken
Open Access

Toxoplasma gondii macrophage migration inhibitory factor shows anti– Mycobacterium tuberculosis potential via AZIN1/STAT1 interaction

Chanjin Yoon iD, Hyo Keun Kim, Yu Seong Ham, Woo Jin Gil, Seok-Jun Mun, Euni Cho iD, Jae-Min Yuk iD, Chul-Su Yang iD

Science Advances · 2024

DOI: 10.1126/sciadv.adq0101 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Chanjin Yoon und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Life Science, Hanyang University, Ansan 15588, South Korea. Hauptthemen laut MEDLINE: Toxoplasma, Chemotactic Factors, Anti-Bacterial Agents, Signal Transduction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycobacterium tuberculosis (MTB) is a pathogenic bacterium, belonging to the family Mycobacteriaceae , that causes tuberculosis (TB). Toxoplasma gondii macrophage migration inhibitory factor (TgMIF), a protein homolog of macrophage migration inhibitory factor, has been explored for its potential to modulate immune responses during MTB infections. We observed that TgMIF that interacts with CD74, antizyme inhibitor 1 (AZIN1), and signal transducer and activator of transcription 1 (STAT1) modulates endocytosis, restoration of mitochondrial function, and macrophage polarization, respectively. These interactions promote therapeutic efficacy in mice infected with MTB, thereby presenting a potential route to host-directed therapy development. Furthermore, TgMIF, in combination with first-line TB drugs, significantly inhibited drug-resistant MTB strains, including multidrug-resistant TB. These results demonstrate that TgMIF is potentially a multifaceted therapeutic agent against TB, acting through immune modulation, enhancement of mitochondrial function, and dependent on STAT1 and AZIN1 pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ToxoplasmaChemotactic FactorsAnti-Bacterial AgentsSignal TransductionMycobacterium tuberculosisTuberculosisProtein BindingSTAT1 Transcription FactorCarrier ProteinsAnimalsMiceHistocompatibility Antigens Class IIAntigens, Differentiation, B-LymphocyteEndocytosisBinding SitesMitochondriaDrug Resistance, BacterialMaleFemaleMice, Inbred C57BLHumansCell LineMice, KnockoutLung Injury

Substanzen

macrophage migration enhancement factorChemotactic FactorsAnti-Bacterial AgentsSTAT1 Transcription Factorornithine decarboxylase antizyme inhibitorCarrier Proteinsinvariant chainHistocompatibility Antigens Class IIAntigens, Differentiation, B-Lymphocyte

Autor:innen und Institutionen

  • Department of Molecular and Life Science, Hanyang University, Ansan 15588, South Korea.
  • Institute of Natural Science & Technology, Hanyang University, Ansan 15588, South Korea.
  • Department of Bionano Engineering, Hanyang University, Seoul 04673, South Korea.
  • Department of Infection Biology and Infection Control Convergence Research Center, College of Medicine, Chungnam National University, Daejeon 35015, South Korea.
  • Department of Medicinal and Life Science, Hanyang University, Ansan 15588, South Korea.

ORCID-Profile: Chanjin Yoon, Euni Cho, Jae-Min Yuk, Chul-Su Yang

Zitieren

APA

Yoon, C., Kim, H. K., Ham, Y. S., Gil, W. J., Mun, S. J., Cho, E., Yuk, J. M., & Yang, C. S. (2024). Toxoplasma gondii macrophage migration inhibitory factor shows anti– Mycobacterium tuberculosis potential via AZIN1/STAT1 interaction. Science Advances. https://doi.org/10.1126/sciadv.adq0101

Vancouver

Yoon C, Kim HK, Ham YS, Gil WJ, Mun SJ, Cho E, et al. Toxoplasma gondii macrophage migration inhibitory factor shows anti– Mycobacterium tuberculosis potential via AZIN1/STAT1 interaction. Science Advances. 2024. doi:10.1126/sciadv.adq0101

BibTeX
@article{Yoon2024,
  author = {Yoon, Chanjin and Kim, Hyo Keun and Ham, Yu Seong and Gil, Woo Jin and Mun, Seok-Jun and Cho, Euni and Yuk, Jae-Min and Yang, Chul-Su},
  title = {Toxoplasma gondii macrophage migration inhibitory factor shows anti– Mycobacterium tuberculosis potential via AZIN1/STAT1 interaction},
  journal = {Science Advances},
  year = {2024},
  doi = {10.1126/sciadv.adq0101}
}
Kostenlos starten →